MedTrace Logo

A Pharmacokinetic Study of TQB3101 in Chinese Healthy Subjects

NCT04804904 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2022-01-21

No results posted yet for this study

Summary

Evaluate the effect of food on the pharmacokinetics of TQB3101 in healthy subjects.

Conditions

  • Pharmacokinetic Study

Interventions

DRUG

TQ-B3101

TQ-B3101 oral capsule

Sponsors & Collaborators

  • Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

    lead INDUSTRY

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-05-20
Primary Completion
2021-06-15
Completion
2021-07-03

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04804904 on ClinicalTrials.gov